Binoy Appukuttan

This inventor holds 9 USPTO granted patents and 1 published patent application, plus 3 CIPO patents and 5 EPO patents. Top assignees: Research Development Foundation, Oregon Health & Science University. Active years: 2006-2021.

USPTO Granted Patents = 9 (Patent Applications = 1)

% Patents Active = 33.3

CIPO Patents = 3

EPO Patents = 5 (Patent Applications = 4)

Average Co-Inventor Count = 3.1

ph-index = 2

Forward Citations = 16(Granted Patents)

Location History:

Adelaide, AU (2017 - 2018)
Portland, OR (US) (2006 - 2021)

Company Filing History:

8 out of 299

Research Development Foundation

patents

3 out of 524

Oregon Health & Science University

patents

where one patent can have more than one assignee

Years Active: 2006-2021

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11098097 - Recombinant filaggrin polypeptides for cell importation (2021-08-24),

2. 10336797 - Recombinant filaggrin polypeptides for cell importation (2019-07-02),

3. 9937269 - RTEF-1 variants and the use thereof for inhibition of angiogenesis (2018-04-10),

4. 9650426 - RTEF-1 variants and uses thereof (2017-05-16),

5. 9512423 - RTEF-1 variants and the use thereof for inhibition of angiogenesis (2016-12-06),

6. 8785385 - RTEF-1 variants and uses thereof (2014-07-22),

7. 8748379 - RTEF-1 variants and the use thereof for inhibition of angiogenesis (2014-06-10),

8. 7557197 - Human soluble neuropilin-1 primary polyadenylation signal and uses thereof (2009-07-07),

9. 7122181 - Lentiviral vector-mediated gene transfer and uses thereof (2006-10-17),

Title: The Innovations of Binoy Appukuttan

Introduction

Binoy Appukuttan is a notable inventor based in Portland, OR (US). He has made significant contributions to the field of biotechnology, particularly in the development of recombinant polypeptides. With a total of 9 patents to his name, Appukuttan's work has the potential to impact various medical applications.

Latest Patents

One of his latest patents focuses on recombinant filaggrin polypeptides for cell importation. This invention discloses recombinant polypeptides that include a filaggrin amino acid sequence and a cell importation signal sequence. The signal sequence contains a motif of two to fifteen amino acids, which includes at least one arginine residue and at least one methionine residue. Additionally, the patent covers nucleic acids encoding these recombinant polypeptides, as well as compositions that include them. The methods outlined in this patent aim to treat or prevent skin diseases or disorders, and it also includes kits containing the recombinant polypeptides.

Career Highlights

Throughout his career, Binoy Appukuttan has worked with esteemed organizations such as the Research Development Foundation and Oregon Health & Science University. His experience in these institutions has allowed him to collaborate on various innovative projects and contribute to advancements in his field.

Collaborations

Some of his notable coworkers include J Timothy Stout and Trevor McFarland. Their collaborative efforts have further enhanced the research and development of new technologies in biotechnology.

Conclusion

Binoy Appukuttan's contributions to the field of biotechnology through his patents and collaborations highlight his innovative spirit and dedication to improving medical treatments. His work continues to pave the way for advancements in the understanding and treatment of skin diseases.